The Kellogg Eye Center is now offering the first FDA-approved retinal implant for people with late-stage retinitis pigmentosa.
The retinal prosthesis, Argus II.
The system includes glasses, VPU, and a cable. The individual wears glasses equipped with a camera that captures images and converts them into a series of small electrical pulses.
The pulses are transmitted wirelessly to the prosthesis and its array of electrodes on the surface of the retina.